Blood Pressure Patterns in Pheochromocytoma
Patients with pheochromocytoma typically present with sustained hypertension (50% of cases) or paroxysmal hypertension (approximately 45% of cases), with approximately 95% demonstrating some form of hypertension, though the blood pressure pattern is highly variable and characterized by marked blood pressure variability rather than a single "typical" value. 1
Blood Pressure Characteristics
Pattern Distribution
- Sustained hypertension: Present in approximately 50% of patients 1
- Paroxysmal hypertension: Occurs in the remaining cases, often with dramatic episodic elevations
- Severe hypertension: Defined as BP ≥180/110 mm Hg, commonly seen in pheochromocytoma patients 2, 3, 4
- Normotensive periods: Can occur between episodes in patients with paroxysmal presentations
Key Distinguishing Feature: Blood Pressure Variability
The hallmark of pheochromocytoma is increased blood pressure variability, which represents an independent cardiovascular risk factor beyond the absolute blood pressure elevation itself 1. This variability is directly related to norepinephrine secretion levels by the tumor 1.
Paradoxical Finding
Importantly, pheochromocytoma patients may actually have lower average blood pressure readings than patients with essential hypertension (153/91 ± 35/15 mm Hg vs 170/103 ± 18/8 mm Hg), yet they experience significantly higher cardiovascular morbidity (13.8% vs 1.1% event rate) 5. This underscores that the toxic effects of catecholamines and blood pressure variability—not just the absolute pressure—drive cardiovascular risk.
Clinical Presentation Patterns
Catecholamine Profile Influences Presentation
- Noradrenergic tumors: Associated with more sustained hypertension and higher likelihood of symptomatic presentation 6, 7
- Mixed secretion patterns: May produce more variable blood pressure patterns
- The degree of blood pressure variability correlates with norepinephrine secretion levels 1
Circadian Rhythm Disruption
Pheochromocytoma characteristically disrupts normal circadian blood pressure patterns 6. Catecholamine excretion correlates with:
- Maximum diastolic blood pressure (correlated with daytime noradrenaline)
- Timing of blood pressure peaks (acrophase)
- Loss of normal nocturnal blood pressure dipping
Clinical Pitfalls
Common Diagnostic Delays
Despite improved diagnostics, there remains an average 3-year delay between initial symptoms and diagnosis 1. Autopsy studies reveal that:
- Tumors are found in 0.05-0.1% of unselected autopsies 8
- Pheochromocytoma contributed to 55% of deaths in cases where it was present
- The diagnosis was not suspected in 75% of fatal cases 1
When to Suspect Pheochromocytoma
Screen patients presenting with:
- Classic triad: Headaches, palpitations, and sweating occurring episodically (90% diagnostic specificity) 1
- Paroxysmal or severe sustained hypertension (BP ≥180/110 mm Hg) refractory to usual therapy 2, 3, 4
- Hypertension triggered by β-blockers, monoamine oxidase inhibitors, micturition, or changes in abdominal pressure 2, 3, 4
- Incidentally discovered adrenal mass 2, 3, 4
- Family history of hereditary syndromes (MEN2, VHL, neurofibromatosis) 2, 3, 4
Screening Approach
Plasma free metanephrines (normetanephrine and metanephrine) is the best screening test, with 99% sensitivity and 89% specificity 1. Alternatively, 24-hour urinary fractionated metanephrines can be used with 90-95% sensitivity 8, 9.
Pediatric Considerations
In children with hypertension, pheochromocytoma prevalence is approximately 1.7% 8, and persistent hypertension is more common than paroxysmal hypertension in this population 10, 11. Genetic mutations are present in 70-80% of pediatric cases 10, making genetic testing essential in all confirmed pediatric pheochromocytoma patients.